Literature DB >> 24898924

Frontal cortex BOLD signal changes in premanifest Huntington disease: a possible fMRI biomarker.

Stefania Ferraro1, Lorenzo Nanetti2, Sylvie Piacentini1, Maria L Mandelli1, Nicola Bertolino1, Francesco Ghielmetti1, Francesca Epifani1, Anna Nigri1, Franco Taroni1, Maria G Bruzzone1, Stefano Di Donato1, Mario Savoiardo1, Caterina Mariotti1, Marina Grisoli1.   

Abstract

OBJECTIVE: To identify a possible functional imaging biomarker sensitive to the earliest neural changes in premanifest Huntington disease (preHD), allowing early therapeutic approaches aimed at preventing or delaying clinical onset.
METHODS: Sixteen preHD and 18 healthy participants were submitted to anatomical acquisitions and functional MRI (fMRI) acquisitions during the execution of the exogenous covert orienting of attention task. Due to strong a priori hypothesis, all fMRI correlation analyses were restricted to the following: (1) the frontal oculomotor cortex identified by the means of a prosaccadic task, comprising frontal eye fields and supplementary frontal eye fields; and (2) the data collected during inhibition of return, a phenomenon occurring during the executed task. In preHD, multiple regression analysis was performed between fMRI data and the probability to develop the disease in the next 5 years (p5HD). Moreover, mean blood oxygen level-dependent (BOLD) signal changes in the frontal oculomotor cortex and striatal volumes were linearly correlated with p5HD.
RESULTS: In preHD, multiple regression analysis showed that clusters of activity strongly correlated with p5HD in the right frontal oculomotor cortex. Importantly, mean BOLD signal changes of this region correlated with p5HD (r(2) = 0.52). Among the considered striatal volumes, a modest correlation (r(2) = 0.29) was observed in the right putamen and p5HD.
CONCLUSION: fMRI activations in the right-frontal oculomotor cortex during inhibition of return can be considered a possible functional imaging biomarker in preHD.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24898924      PMCID: PMC4114171          DOI: 10.1212/WNL.0000000000000538

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  Functional imaging of neural responses to expectancy and experience of monetary gains and losses.

Authors:  H C Breiter; I Aharon; D Kahneman; A Dale; P Shizgal
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

2.  A common network of functional areas for attention and eye movements.

Authors:  M Corbetta; E Akbudak; T E Conturo; A Z Snyder; J M Ollinger; H A Drury; M R Linenweber; S E Petersen; M E Raichle; D C Van Essen; G L Shulman
Journal:  Neuron       Date:  1998-10       Impact factor: 17.173

Review 3.  Development of biomarkers for Huntington's disease.

Authors:  David W Weir; Aaron Sturrock; Blair R Leavitt
Journal:  Lancet Neurol       Date:  2011-06       Impact factor: 44.182

4.  Puzzlingly High Correlations in fMRI Studies of Emotion, Personality, and Social Cognition.

Authors:  Edward Vul; Christine Harris; Piotr Winkielman; Harold Pashler
Journal:  Perspect Psychol Sci       Date:  2009-05

5.  Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease.

Authors:  Paul G Unschuld; Suresh E Joel; Xinyang Liu; Megan Shanahan; Russell L Margolis; Kevin M Biglan; Susan S Bassett; David J Schretlen; Graham W Redgrave; Peter C M van Zijl; James J Pekar; Christopher A Ross
Journal:  Neurosci Lett       Date:  2012-03-07       Impact factor: 3.046

6.  Basal ganglia volume and proximity to onset in presymptomatic Huntington disease.

Authors:  E H Aylward; A M Codori; P E Barta; G D Pearlson; G J Harris; J Brandt
Journal:  Arch Neurol       Date:  1996-12

7.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

8.  Orienting of spatial attention in Huntington's Disease.

Authors:  Maryline Couette; Anne-Catherine Bachoud-Levi; Pierre Brugieres; Eric Sieroff; Paolo Bartolomeo
Journal:  Neuropsychologia       Date:  2007-12-27       Impact factor: 3.139

9.  Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease.

Authors:  Marianne J U Novak; Jason D Warren; Susie M D Henley; Bogdan Draganski; Richard S Frackowiak; Sarah J Tabrizi
Journal:  Brain       Date:  2012-04       Impact factor: 13.501

10.  Functional compensation of motor function in pre-symptomatic Huntington's disease.

Authors:  Stefan Klöppel; Bogdan Draganski; Hartwig R Siebner; Sarah J Tabrizi; Cornelius Weiller; Richard S J Frackowiak
Journal:  Brain       Date:  2009-04-15       Impact factor: 13.501

View more
  3 in total

1.  T1ρ imaging in premanifest Huntington disease reveals changes associated with disease progression.

Authors:  Shafik N Wassef; John Wemmie; Casey P Johnson; Hans Johnson; Jane S Paulsen; Jeffrey D Long; Vincent A Magnotta
Journal:  Mov Disord       Date:  2015-03-29       Impact factor: 10.338

2.  Analytical Techniques in Neuroscience: Recent Advances in Imaging, Separation, and Electrochemical Methods.

Authors:  Mallikarjunarao Ganesana; Scott T Lee; Ying Wang; B Jill Venton
Journal:  Anal Chem       Date:  2016-11-22       Impact factor: 6.986

3.  Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model.

Authors:  Dohee Kim; Jeha Jeon; Eunji Cheong; Dong Jin Kim; Hoon Ryu; Hyemyung Seo; Yun Kyung Kim
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.